BGI Group

BGI Group is a multinational genomics company founded in 1999 in China.

Initially established to support the Human Genome Project, it has grown into a leader in genomic sequencing, proteomics, and precision medicine, serving customers in over 100 countries. The company employs around 10,000 people and has a global presence with collaborations across North America, Europe, and Asia. BGI Group offers a range of advanced instruments and diagnostic tests, including the DNBseq Platform for next-generation sequencing and the NIFTY Test, a non-invasive prenatal test. Its services encompass genomic and proteomic analysis, clinical molecular diagnostics, and bioinformatics, catering to academic institutions, pharmaceutical companies, healthcare providers, and public health organizations. The company is committed to driving technological advancements in areas such as cancer research and personalized medicine.